Statistics for Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension
Total visits
| views | |
|---|---|
| Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension | 55 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:a466a629-377e-40c2-b44b-1c2f9b71536f | 59 |
| rmdopen-2021-001714.pdf | 55 |
| java.util.UUID:06bceaf4-8e92-4e68-9411-f027cdc29ae4 | 17 |
| java.util.UUID:ab56a61d-d1e8-4fef-bca8-f4d478cf23b8 | 6 |
Top country views
| views | |
|---|---|
| United States | 48 |
| France | 2 |
Top city views
| views | |
|---|---|
| Wilmington | 41 |
| Ann Arbor | 2 |
| Paris | 2 |
| Cambridge | 1 |
| Fairfield | 1 |
| Grayslake | 1 |
| Indianapolis | 1 |